7-OH Use in Pregnancy: Risks to Mother and Baby

What is 7-Hydroxymitragynine (7-OH)?

7-Hydroxymitragynine (7-OH) is a naturally occurring alkaloid found in the kratom plant (Mitragyna speciosa). It is considered one of the primary active compounds in kratom and is believed to contribute significantly to its effects. While kratom has been used traditionally in some cultures, scientific understanding of 7-OH, especially its long-term effects and safety profile, is still developing.

Due to its potent nature, 7-OH is often isolated or concentrated in some kratom products. However, the regulatory status and quality control of such products can vary widely, making their use particularly concerning, especially for vulnerable populations like pregnant individuals.

Why Avoid 7-OH in Pregnancy?

The primary reason to avoid 7-OH during pregnancy is the lack of comprehensive scientific research on its effects on fetal development and maternal health. Most substances, including herbal products, are not rigorously tested for safety in pregnant populations due to ethical concerns. This absence of data means that any use during pregnancy carries an unknown and potentially significant risk.

Healthcare professionals universally advise against the use of any unprescribed or unapproved substances during pregnancy. This recommendation extends to 7-OH and kratom, as their pharmacological actions are complex and could interfere with normal physiological processes critical for a healthy pregnancy and fetal development.

Potential Risks to the Mother

While specific studies on 7-OH in pregnant humans are rare, general concerns related to kratom use can be extrapolated. Pregnant individuals may experience adverse effects that could complicate their pregnancy.

These potential risks may include:

• Nausea and vomiting, which can exacerbate existing morning sickness or lead to dehydration.
• Constipation, a common issue in pregnancy that could be worsened.
• Dizziness or sedation, increasing the risk of falls or accidents.
• Potential for dependence and withdrawal symptoms, which can be particularly distressing and medically complicated during pregnancy.
• Interactions with other medications or supplements, which could lead to unforeseen complications.

Potential Risks to the Baby

The developing fetus is highly vulnerable to substances ingested by the mother. Any substance that crosses the placenta can potentially affect fetal growth, development, and overall health. Given that 7-OH acts on opioid receptors, there is concern about its potential impact on the developing fetal nervous system.

Clinicians report that exposure to kratom, and by extension 7-OH, during pregnancy may lead to neonatal abstinence syndrome (NAS) in newborns. NAS is a group of problems a baby experiences when withdrawing from exposure to certain drugs in the womb. Symptoms can range from mild to severe and may require prolonged hospitalization and specialized care.

Seeking Help and Support

If you are pregnant and using 7-OH or kratom, it is vital to seek medical help immediately. Do not attempt to stop using substances without professional medical supervision, as sudden withdrawal can also pose risks to both mother and baby. Healthcare providers can offer safe, evidence-based strategies for managing substance use during pregnancy.

Support is available, and reaching out is a sign of strength. Confidential resources can help you navigate this challenging time and ensure the best possible outcomes for you and your baby. Early intervention and consistent care are crucial for a healthy pregnancy and a healthy start for your child.